Effect of peritoneal dialysis on expression of vascular endothelial growth factor, basic fibroblast growth factor and endostatin of the peritoneum in peritoneal dialysis patients

Nephrology

Volumn 16, Issue 8, 2011, Pages 736-742

  Gao, Dan ^a   Zhao, Zhan Zheng ^a   Liang, Xian Hui ^a   Li, Yan ^a   Cao, Ying ^a   Liu, Zhang Suo ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Basic fibroblast growth factor; Endostatin; Neoangiogenesis; Peritoneal dialysis; Vascular endothelial growth factor

Indexed keywords

ENDOSTATIN; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CAPILLARY DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEOVASCULARIZATION (PATHOLOGY); PERITONEAL BIOPSY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ULTRAFILTRATION; UPREGULATION; UREMIA; WESTERN BLOTTING;

ADULT; AGED; BIOPSY; ENDOSTATINS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; PERITONEAL DIALYSIS; PERITONEUM; RNA, MESSENGER; UREMIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84055221985     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2011.01502.x     Document Type: Article

References (23)

1. Jiwakanon S, Chiu YW, Kalantar-Zadeh K et al. Peritoneal dialysis: An underutilized modality. Curr. Opin. Nephrol. Hypertens. 2010;19:573-7.
2. Schilte MN, Celie JW, Wee PM et al. Factors contributing to peritoneal tissue remodeling in peritoneal dialysis. Perit. Dial. Int. 2009;29:605-17.
3. Fabbrini P, Schilte MN, Zareie M et al. Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failure in experimental peritoneal dialysis. Nephrol. Dial. Transplant. 2009;24(12):3669-76.
4. Saxena R. Pathogenesis and treatment of peritoneal membrane failure. Pediatr. Nephrol. 2008;23:695-703. (Pubitemid 351486181)
5. Kim YL. Update on mechanisms of ultrafiltration failure. Perit. Dial. Int. 2009;29:123-7.
6. Aroeira LS, Aguilera A, Selgas R et al. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: Role of vascular endothelial growth factor. Am. J. Kidney Dis. 2005;46:938-48. (Pubitemid 41505470)
7. Jing S, Kezhou Y, Hong Z et al. Effect of renin-angiotensin system inhibitors on prevention of peritoneal fibrosis in peritoneal dialysis patients. Nephrology (Carlton) 2010;15(1):27-32.
8. Mujais S, Nolph K, Gokal R et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit. Dial. Int. 2000;20(4):5-21.
9. Nakao A, Nakao K, Takatori Y et al. Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy. Nephrol. Dial. Transplant. 2010;25(5):1479-88.
10. Kakuta T, Tanaka R, Satoh Y et al. Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats. Kidney Int. 2005;68(3):1326-36. (Pubitemid 43246454)
11. Tanabe K, Maeshima Y, Ichinose K et al. Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model. Kidney Int. 2007;71:227-38. (Pubitemid 46160923)
12. Weidner N. Intratumor microvessel density as prognostic factor in cancer. Am. J. Pathol. 1995;147:33-41.
13. Williams JD, Craig KJ, Topley N et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J. Am. Soc. Nephrol. 2002;13:470-9. (Pubitemid 34106290)
14. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-64. (Pubitemid 26272076)
15. Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int. 1999;56:794-814. (Pubitemid 29411709)
16. Bellini MH, Coutinho EL, Filgueiras TC et al. Endostatin expression in the murine model of ischaemia/reperfusion-induced acute renal failure. Nephrology (Carlton) 2007;12:459-65. (Pubitemid 47366650)
17. Uematsu S, Higashi T, Nouso K et al. Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2005;20:583-8. (Pubitemid 40755271)
18. Aroeira LS, Aquilera A, Selgas R et al. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: Role of vascular endothelial growth factor. Am. J. Kidney Dis. 2005;46:938-48. (Pubitemid 41505470)
19. Sasaki T, Larsson H, Kreuger J et al. Structure basis and potential of heparin/hepatan sulfate binding to the angiogenesie inhibitor endostatin. EMBO J. 1999;18:6240-8. (Pubitemid 29533228)
20. Kim YM, Hwang S, Kim YM et al. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J. Biol. Chem. 2002;277:27872-9. (Pubitemid 34966733)
21. Tanabe K, Maeshima Y, Ichinose K et al. Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model. Kidney Int. 2007;71:227-38. (Pubitemid 46160923)
22. Wenzel D, Schmidt A, Riemann K et al. Endostatin, the proteolytic fragment of collagen XVIII, induces vasorelaxation. Circ. Res. 2006;98:1203-11. (Pubitemid 43948107)
23. Zhao ZZ, Cao Y, Liu ZS et al. The Effects of recombinant human endostatin on peritoneal angiogenesis in peritoneal dialysis rats. Nephrology (Carlton) 2011;16:599-606.